Community-Acquired Pneumonia in Patients With Diabetes: Narrative Review
CAP in patients with diabetes is a distinct, more severe entity mediated by metabolic-immune crosstalk. Multicenter randomized controlled trials integrating tight glucose monitoring, novel host-directed agents, and microbiome modulation are warranted to translate mechanistic insights into better outcomes.
Authors
- Ruilan Wang (ORCID: https://orcid.org/0000-0001-9555-2649)
- Yun Xie
- Ying Wang
- Ao Zhang
Institutions
- Shanghai Jiao Tong University (CN)
- Ministry of Education (TH)
- Shanghai First People's Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- JMIR Diabetes
- Published
- 2026-01-03
- DOI
- https://doi.org/10.2196/82215
- Primary Topic
- Chronic Disease Management Strategies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science and Technology Major Project
- Center for Clinical and Translational Research
- National Key Research and Development Program of China